PMID- 23595987 OWN - NLM STAT- MEDLINE DCOM- 20130806 LR - 20211021 IS - 1083-351X (Electronic) IS - 0021-9258 (Print) IS - 0021-9258 (Linking) VI - 288 IP - 22 DP - 2013 May 31 TI - cAMP-responsive element-binding protein (CREB)-regulated transcription coactivator 2 (CRTC2) promotes glucagon clearance and hepatic amino acid catabolism to regulate glucose homeostasis. PG - 16167-76 LID - 10.1074/jbc.M113.460246 [doi] AB - cAMP-responsive element-binding protein (CREB)-regulated transcription coactivator 2 (CRTC2) regulates transcription of gluconeogenic genes by specifying targets for the transcription factor CREB in response to glucagon. We used an antisense oligonucleotide directed against CRTC2 in both normal rodents and in rodent models of increased gluconeogenesis to better understand the role of CRTC2 in metabolic disease. In the context of severe hyperglycemia and elevated hepatic glucose production, CTRC2 knockdown (KD) improved glucose homeostasis by reducing endogenous glucose production. Interestingly, despite the known role of CRTC2 in coordinating gluconeogenic gene expression, CRTC2 KD in a rodent model of type 2 diabetes resulted in surprisingly little alteration of glucose production. However, CRTC2 KD animals had elevated circulating concentrations of glucagon and a approximately 80% reduction in glucagon clearance. When this phenomenon was prevented with somatostatin or a glucagon-neutralizing antibody, endogenous glucose production was reduced by CRTC2 KD. Additionally, CRTC2 inhibition resulted in reduced expression of several glucagon-induced pyridoxal 5'-phosphate-dependent enzymes that convert amino acids to gluconeogenic intermediates, suggesting that it may control substrate availability as well as gluconeogenic gene expression. CRTC2 is an important regulator of gluconeogenesis with tremendous impact in models of elevated hepatic glucose production. Surprisingly, it is also part of a previously unidentified negative feedback loop that degrades glucagon and regulates amino acid metabolism to coordinately control glucose homeostasis in vivo. FAU - Erion, Derek M AU - Erion DM AD - Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06536, USA. FAU - Kotas, Maya E AU - Kotas ME FAU - McGlashon, Jacob AU - McGlashon J FAU - Yonemitsu, Shin AU - Yonemitsu S FAU - Hsiao, Jennifer J AU - Hsiao JJ FAU - Nagai, Yoshio AU - Nagai Y FAU - Iwasaki, Takanori AU - Iwasaki T FAU - Murray, Susan F AU - Murray SF FAU - Bhanot, Sanjay AU - Bhanot S FAU - Cline, Gary W AU - Cline GW FAU - Samuel, Varman T AU - Samuel VT FAU - Shulman, Gerald I AU - Shulman GI FAU - Gillum, Matthew P AU - Gillum MP LA - eng GR - R01 DK-40936/DK/NIDDK NIH HHS/United States GR - HHMI/Howard Hughes Medical Institute/United States GR - U24 DK059635/DK/NIDDK NIH HHS/United States GR - P30 DK-45735/DK/NIDDK NIH HHS/United States GR - R01 DK040936/DK/NIDDK NIH HHS/United States GR - P30 DK045735/DK/NIDDK NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20130417 PL - United States TA - J Biol Chem JT - The Journal of biological chemistry JID - 2985121R RN - 0 (Amino Acids) RN - 0 (Antibodies, Neutralizing) RN - 0 (CRTC2 protein, rat) RN - 0 (Crtc2 protein, mouse) RN - 0 (Trans-Activators) RN - 0 (Transcription Factors) RN - 5V5IOJ8338 (Pyridoxal Phosphate) RN - 9007-92-5 (Glucagon) RN - IY9XDZ35W2 (Glucose) SB - IM MH - Amino Acids/genetics/*metabolism MH - Animals MH - Antibodies, Neutralizing/pharmacology MH - Diabetes Mellitus, Experimental/genetics/metabolism/pathology MH - Gene Knockdown Techniques MH - Glucagon/antagonists & inhibitors/genetics/*metabolism MH - Gluconeogenesis/drug effects/genetics MH - Glucose/genetics/*metabolism MH - *Homeostasis MH - Liver/*metabolism/pathology MH - Mice MH - Pyridoxal Phosphate/genetics/metabolism MH - Rats MH - Trans-Activators/genetics/*metabolism MH - Transcription Factors/genetics/*metabolism PMC - PMC3668772 OTO - NOTNLM OT - Amino Acid OT - CRTC2 OT - Diabetes OT - Glucagon OT - Gluconeogenesis OT - Liver OT - Physiology EDAT- 2013/04/19 06:00 MHDA- 2013/08/07 06:00 PMCR- 2014/05/31 CRDT- 2013/04/19 06:00 PHST- 2013/04/19 06:00 [entrez] PHST- 2013/04/19 06:00 [pubmed] PHST- 2013/08/07 06:00 [medline] PHST- 2014/05/31 00:00 [pmc-release] AID - S0021-9258(20)46002-8 [pii] AID - M113.460246 [pii] AID - 10.1074/jbc.M113.460246 [doi] PST - ppublish SO - J Biol Chem. 2013 May 31;288(22):16167-76. doi: 10.1074/jbc.M113.460246. Epub 2013 Apr 17.